Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Batra V, Samanta M, Makvandi M, Groff D, Martorano P, Elias J, Ranieri P, Tsang M, Hou C, Li Y, Pawel B, Martinez D, Vaidyanathan G, Carlin S, Pryma DA, Maris JM.
Batra V, et al. Among authors: vaidyanathan g.
Clin Cancer Res. 2022 Sep 15;28(18):4146-4157. doi: 10.1158/1078-0432.CCR-22-0400.
Clin Cancer Res. 2022.
PMID: 35861867
Free PMC article.